ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 121 filers reported holding ANI PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.17 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $221,216 | -9.3% | 3,200 | -23.8% | 0.00% | – |
Q3 2023 | $243,852 | +5.6% | 4,200 | -47.5% | 0.00% | – |
Q1 2022 | $231,000 | -21.7% | 8,000 | +27.0% | 0.00% | – |
Q4 2021 | $295,000 | +2.1% | 6,300 | -37.6% | 0.00% | – |
Q4 2020 | $289,000 | -55.1% | 10,100 | -11.4% | 0.00% | -100.0% |
Q3 2018 | $644,000 | -28.2% | 11,400 | -26.0% | 0.00% | 0.0% |
Q2 2018 | $897,000 | 0.0% | 15,400 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $897,000 | +7.3% | 15,400 | +18.7% | 0.00% | -33.3% |
Q4 2017 | $836,000 | -38.6% | 12,978 | -55.0% | 0.00% | -50.0% |
Q2 2017 | $1,362,000 | -37.8% | 28,854 | -34.5% | 0.01% | -50.0% |
Q1 2017 | $2,188,000 | +534.2% | 44,065 | +673.9% | 0.01% | +500.0% |
Q4 2016 | $345,000 | -87.3% | 5,694 | -88.2% | 0.00% | -86.7% |
Q2 2016 | $2,719,000 | – | 48,400 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
FIRST WILSHIRE SECURITIES MANAGEMENT INC | 367,754 | $10,911,000 | 4.08% |
AIGH Capital Management LLC | 244,500 | $7,254,000 | 1.91% |
Parkman Healthcare Partners LLC | 108,559 | $3,221,000 | 1.19% |
Worth Venture Partners, LLC | 60,831 | $1,927,000 | 1.13% |
Global Alpha Capital Management Ltd. | 323,731 | $9,605,000 | 1.04% |
Mesirow Financial Investment Management, Inc. | 6,892 | $204,000 | 0.99% |
MARATHON CAPITAL MANAGEMENT | 74,460 | $2,209,000 | 0.71% |
EMERALD ADVISERS, LLC | 455,880 | $13,526,000 | 0.70% |
EMERALD MUTUAL FUND ADVISERS TRUST | 356,865 | $10,588,000 | 0.61% |
Jackson Creek Investment Advisors LLC | 32,698 | $1,120,000 | 0.45% |